Apostrophe has been acquired by Hims & Hers Health, Inc.

Lipiec 2021 — The private shareholders of Apostrophe have sold the company to Hims & Hers Health, Inc.

Founded in 2012 and based in Oakland, California, Apostrophe is a direct-to-patient teledermatology platform that provides individuals with access to tailored, clinical-quality treatment plans that are prescribed by board-certified dermatologists. Through its vertically integrated in-house pharmacy, the company creates premium Apostrophe-branded products that use bespoke combinations of topical formulas and oral medications to meet the unique needs of patients. Driven by its innovative telehealth model, well-recognized skincare brand and visionary leadership team, the company has experienced rapid growth over the past several years.

Based in San Francisco, California, Hims & Hers is a leading multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers.

Nasza rola w transakcji

Oaklins’ team in Los Angeles acted as advisor to the private shareholders of Apostrophe in this transaction.